Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes
Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000
Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992
Dantrolene Sodium and Hepatic Injury
Neurol 40:1427-1432, Chan,C.H., 1990
Phenelzine Toxicity Responsive to Dantrolene
Neurol 37:865-867, Verrilli,M.R.,et al, 1987
Spasticity
et al (Part 1 & 2) NEJM 304:28-33, 96-99., Young,R.R., 1981
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
The Malignant Hyperthermia Syndrome
NEJM 309:416-418, Nelson,T.E.,et al, 1983
Beneficial Effects of Dantrolene in the Treatment of Neuroleptic Malignant Syndrome:A Report of Two Cases
Neurol 33:516-518, Goulon,M.,et al, 1983
Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983
Pleuropericardial Reaction to Treatment With Dantrolene
JAMA 242:2772--2774, Petusevsky,M.L.,et al, 1979
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975